Sanofi (Kardégic) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Sanofi (Kardégic) General Information
Description
A pharmaceutical brand. The medicine is indicated for the prevention of cardiovascular events and provides antiplatelet therapy to reduce the risk of blood clots, heart attacks, and strokes.
Contact Information
Corporate Office
- Gentilly
- France
Corporate Office
- Gentilly
- France
Sanofi (Kardégic) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sanofi (Kardégic) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sanofi (Kardégic) FAQs
-
Where is Sanofi (Kardégic) headquartered?
Sanofi (Kardégic) is headquartered in Gentilly, France.
-
What industry is Sanofi (Kardégic) in?
Sanofi (Kardégic)’s primary industry is Buildings and Property.
-
Is Sanofi (Kardégic) a private or public company?
Sanofi (Kardégic) is a Private company.
-
What is Sanofi (Kardégic)’s current revenue?
The current revenue for Sanofi (Kardégic) is .
-
Who are Sanofi (Kardégic)’s investors?
Sanofi has invested in Sanofi (Kardégic).
-
When was Sanofi (Kardégic) acquired?
Sanofi (Kardégic) was acquired on 31-Oct-2025.
-
Who acquired Sanofi (Kardégic)?
Sanofi (Kardégic) was acquired by Substipharm.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process